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Background: COPD patients have decreased physical fitness, and have an increased risk of vascular disease. In the
general population, fitness is positively associated with resting cerebral blood flow velocity, however, little is known
about the cerebrovascular response during exercise particularly in COPD patients. We hypothesized that COPD
patients would have lower cerebral blood flow during exercise secondary to decreased physical fitness and
underlying vascular disease.
Methods: Cardiopulmonary exercise testing was conducted in 11 women with GOLD stage I-II COPD, and 11
healthy controls to assess fitness. Cerebro- and cardio-vascular responses were compared between groups during
two steady-state exercise tests (50% peak O2 consumption and 30 W). The main outcome variable was peak middle
cerebral artery blood flow velocity (VP) during exercise using transcranial Doppler ultrasonography.
Results: Physical fitness was decreased in COPD patients. VP was comparable between COPD and controls
(25 ± 22% versus 15 ± 13%, respectively; P > 0.05) when exercising at the same relative intensity, despite patients having
higher blood pressure and greater arterial desaturation. However, VP was elevated in COPD (31 ± 26% versus 13 ± 10%;
P≤ 0.05) when exercising at the same workload as controls.
Conclusions: Our results are contradictory to our a-priori hypothesis, suggesting that during matched intensity exercise,
cerebral blood flow velocity is similar between COPD and controls. However, exercise at a modestly greater workload
imposes a large physical demand to COPD patients, resulting in increased CBF compared to controls. Normal activities of
daily living may therefore impose a large cerebrovascular demand in COPD patients, consequently reducing their
cerebrovascular reserve capacity.
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The regulation of cerebral blood flow (CBF) is impera-
tive for adequate delivery of O2 and energy supply to the
brain. During cerebral activation and increased metabol-
ism, cerebral arterioles dilate, thereby increasing CBF,
and ultimately O2 delivery. This process of neurovascular
coupling (i.e., neural activation coupled with an adequate
increase in blood flow) is challenged during dynamic exer-
cise. Factors such as age and physical fitness have been
suggested to play an important role in this regulatory
process both at rest [1], and during exercise [2].* Correspondence: poulin@ucalgary.ca
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reproduction in any medium, provided the orThe reduction of physical activity levels and exercise
capacity in COPD patients [3-5] may pose a risk to pa-
tients’ cerebrovascular health. Even in the early stages of
COPD, patients with mild and moderate obstruction are
reported to have reduced exercise capacity [6]. Evidence
suggests that patients with moderate COPD are already
at an increased risk of cardiovascular disease and stroke,
thereby suggesting an underlying vascular pathology. We
have previously reported decreased CBF responsiveness
to CO2 in women with COPD, suggesting reduced cere-
bral dilatory function [7].
Cycle ergometry testing offers a functional and transla-
tional tool to test integrated responses during exercise.
COPD patients may exhibit arterial hypercapnia [8] and
hypoxemia, exaggerated vasopressor response [9], and
ventilatory limitations [10] during exercise – which allral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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more, greater distribution of cardiac output to respira-
tory or peripheral muscles could impact the blood flow
delivery to the brain. Presently, few studies have focused
on the cerebrovascular response of COPD patients dur-
ing exercise [11,12], and of these studies, focus has been
on exercise limitations. It is currently unknown if the
cerebrovascular response to exercise in COPD patients
differs from that of a healthy control group.
We therefore tested the hypothesis that women with
mild-moderate COPD would have reduced cerebral
blood flow during exercise, secondary to reduced phys-
ical fitness. Women were of particular interest in this
study due to a shift in the disease burden from men to
women [13], and comparatively, women report worse
symptoms for a similar severity of disease to men, and
for any given age, have lower aerobic capacity. Addition-
ally, we chose to focus on patients with mild-moderate
COPD because this demographic represents approxi-
mately half of all cases of COPD [14].
Methods
Study subjects
Twenty-three postmenopausal women (COPD = 11,
Healthy Control = 12) between the ages of 55–79 years
old were recruited for participation in this study. Control
subjects were recruited from the community, and COPD
patients were recruited from participating outpatient
medical clinics within the Calgary Health Region. All
study participants visited the Laboratory of Human Cere-
brovascular Physiology at the University of Calgary (1103 m
elevation) for two testing sessions. Subjects were instructed
to refrain from eating or drinking 4 hours prior to each
testing session. All study participants provided written,
informed consent. Ethical approval was obtained by the
Conjoint Health Research Ethics Board at the University
of Calgary (Ethics ID: E-22138).
Since there are currently no published studies describing
the CBF response in COPD during exercise, compared to
healthy controls, we based our sample size using data
from our previous study [7] describing changes in VP dur-
ing hypercapnia. We expected a similar difference in VP
between groups (Control = 37% vs. COPD = 19%). There-
fore, a sample size of n = 10 in each group was needed to
detect a significant difference with a power of 95%, and
a two-tailed α of 0.05. It is likely that there are similar
physiological mechanisms involved in the regulation of
blood flow during exercise and hypercapnia, and reason
that this power calculation would be an appropriate esti-
mation of sample size.
Inclusion criteria
Patients were eligible for inclusion into the COPD cohort
if they had physician-diagnosed GOLD stage I-II COPD, asmoking history >10 pack-years and, chronic airflow ob-
struction (FEV1/FVC <70%; FEV1 ≥ 50% predicted).
To control for the immediate and lasting cardiovascular
effects of nicotine, patients needed to be ex-smokers
(>1 year). Additional criteria included: post-menopausal
for ≥ 12 months, able to walk independently outside or
on stairs, and a BMI < 35 kg m−2. Study subjects were
allowed to be on long- or short-acting bronchodilators,
either alone, or in combination with inhaled cortico-
steroids. Exclusion criteria included heart/chest pain
upon physical exertion, surgery or trauma within pre-
vious 6 months, history of myocardial infarction, an-
gina, arrhythmia, valve disease, chronic heart failure,
history of stroke, cardiovascular or cerebrovascular dis-
ease, history of chronic headaches/migraines, history of
blood clots/thrombosis, and patients who were on domicil-
iary oxygen.
Participating control subjects were sedentary (< 3 planned
exercise sessions/week), post-menopausal, and had no
history of lung disease, and no significant history of smok-
ing (< 1 pack-year lifetime smoking history). Additional
exclusion criteria conformed to that as outlined above for
COPD patients.
Study design
Subjects visited the laboratory on two occasions, and
followed the same study protocol and procedures. On
the first visit, volunteers completed a medical screening
questionnaire, pulmonary function test, and cardiopul-
monary exercise test (CPET) to assess physical fitness.
Volunteers returned to the laboratory to complete the
main experimental session involving CBF measurements
during exercise. The main exercise protocol consisted
of two bouts of 6-minutes each of exercise on a modi-
fied semi-supine cycle ergometer (~70 degrees upright)
(Exercise 1 [EX1 = 50% _VO2peak and Exercise 2 [EX2 = 30
Watts]), as previously described [15,16]. The workload at
50% _VO2peak was intended to observe the peak CBF re-
sponse, while an absolute value of 30 Watts was selected
to represent the intensity of common activities of daily liv-
ing, comparable to household work and light gardening
(~3 metabolic equivalents; METS). The exercise periods
were separated by a 6-minute rest/recovery period to allow
physiological variables to return to baseline (BL).
Pulmonary function testing
Spirometry, measures of lung volumes and single-breath
diffusion capacity were completed according to ATS
guidelines [17-19].
Cardiopulmonary exercise test
Peak oxygen uptake ( _VO2 peak ) was assessed by a CPET
performed on a modified semi-reclined cycle ergometer,
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with a 3-minute warm-up period of unloaded cycling,
immediately followed by an increase in workload to
20 W, with progressive increments of either 10 or
15 W·min−1 (COPD patients or controls, respectively).
Ratings of perceived dyspnea and leg fatigue were scored
using a modified Borg Scale every 2 minutes by the par-
ticipant. Breath-by-breath metabolic and respiratory vari-
ables were collected using dedicated software (BreatheM
v2.38, Oxford) and measured by mass spectrometry
(AMIS 2000; Innovision, Odense, Denmark). Continuous
measures of heart rate via 3-lead ECG (Micromon 7142
monitor; Kontron Medical, Milton Keynes, UK), and arter-
ial oxygen saturation (SaO2) (Model 3900; Datex-Ohmeda,
Louisville, CO) were recorded.
Protocol to measure the cerebral blood flow response to
submaximal exercise
Middle cerebral artery (MCA) blood flow velocity was
continuously measured using a 2-MHz pulsed Doppler
Ultrasound system (TC22, SciMed, Bristol, England) as
previously described [16]. Peak middle cerebral artery
velocity (VP) was used as a surrogate for CBF. Heart rate
was collected using a 3-lead ECG (Micromon 7142B
monitor; Kontron Keynes, UK), and continuous beat-beat
blood pressure was measured using finger pulse photo-
plethysmography (Portapress; TPD Biomedical Instru-
mentation, Amsterdam, The Netherlands). Arterial oxygen
saturation was collected using finger pulse oximetry
(Model 3900; Datex-Ohmeda, Louisville, CO).
Respiratory measures
Subjects breathed through a mouthpiece with their nose
occluded. Respiratory gas concentrations were sampled
at the mouth at 100Hz using mass spectrometry (AMIS
2000; Innovision, Odense, Denmark). Respiratory volumes
were measured with a turbine and volume transducer
(VMM-400; Interface Associates, Laguna Niguel, CA), and
respiratory flow direction and timing were obtained with




Physiological data were collected on a beat-beat and
breath-breath basis using dedicated software (BreatheM
v2.38, University Laboratory of Physiology, Oxford, UK)
and later averaged into 15-second bins. Baseline data
were averaged over 2-minutes immediately preceding
exercise. To achieve steady state parameters, the last
60-seconds of exercise (i.e., minute 5 to 6) were used
in the stage averages. The main outcome variable in this
study was VP. Secondary outcomes were _VO2peak , meanblood pressure (MBP), and cerebrovascular conductance
(CVC ¼ VP=MBP).
Statistical procedures
Using statistical software (SPSS Version 20.0, SPSS Inc.,
Chicago, IL, USA), mean between-group differences in
subject characteristics, pulmonary function data, and end-
points of the maximal cardiopulmonary exercise test were
determined using independent t-tests. Paired t-tests were
used to assess baseline (BL) differences within groups
(i.e., COPD BL1 vs. COPD BL2). A 2×2 mixed factorial
repeated measures analysis of variance was used to assess
the main effect of independent variables “condition” (i.e.,
BL1 vs. EX1 or BL2 vs. EX2), and “grouping” (i.e., COPD
or CONTROL), and the interaction between condition x
grouping on physiological outcomes (i.e., VP, CVC, MBP,
HR, SaO2).
Relationships were assessed exclusively within groups
using Pearson’s correlation coefficient to investigate fitness
status ( _VO2peak ), disease severity (FEV1pred, DLCO), SaO2,
PETCO2, and MBP on cerebrovascular variables at rest
and during exercise. Data are presented as mean ± SD, with
significance set at α-level ≤ 0.05. Two tailed tests were per-
formed in all analyses.
Results
Two COPD patients were not able to complete the EX2
protocol; however, their data from EX1 was included in
the study analysis. One control participant was excluded
due to lack of a suitable CBF signal. We therefore com-
pared the exercise responses between 11 COPD and 11
control participants in EX1, and 9 COPD and 11 control
participants in EX2.
Baseline characteristics
Physical characteristics and results of pulmonary function
tests are listed in Table 1. Groups were well matched for
age, weight and BMI (P > 0.05). By study design, COPD
patients had a significantly greater smoking history than
controls (P < 0.01). Based on post-spirometric FEV1 pre-
dicted values, disease severity ranged from GOLD I-II
(mild to moderate) (51% to 86%) in COPD patients (n = 9,
GOLD II). COPD patients had reduced diffusion capacity
(DLCO), and increased hyperinflation (FRC, IC/TLC) com-
pared to control subjects (P < 0.01), who all had normal
lung function.
Cardiopulmonary exercise test
Results of the cardiopulmonary exercise test are summa-
rized in Table 2. Mean _VO2peak and peak power output
was lower in patients with COPD. Arterial oxygen satur-
ation was significantly decreased in COPD patients with
exercise, but not in controls (P < 0.01). At end of exercise,
Table 1 Subject characteristics
COPD (n = 11) Controls (n = 11)
Physical Characteristics Mean Mean
Age, years 69.6 ± 5.6 64.2 ± 7.1
Weight, kg 68.8 ± 12.8 69.4 ± 9.6
BMI, kg·m−2 26.8 ± 4.6 25.6 ± 2.7
Smoking Pack-years 38.4 ± 12.9 † 0.2 ± 0.3
Lung Function % Predicted % Predicted
FEV1, L 1.38 ± 0.24 † 67 2.50 ± 0.34 107
FVC, L 2.64 ± 0.51 * 97 3.24 ± 0.38 108
TLC, L 5.53 ± 1.04 115 5.12 ± 0.45 101
RV, L 2.97 ± 0.78 † 146 1.81 ± 0.30 88
FRC, L 3.40 ± 0.77 † 124 2.48 ± 0.34 86
IC, L 2.07 ± 0.50 * 2.52 ± 0.43
IC/TLC,% 37 † 49
RV/TLC,% 53 † 35
DLCO, ml · min
−1 · mmHg−1 14.2 ± 3.3 † 72 21.1 ± 3.1 107
Abbreviations: BMI, Body mass index; FEV1, Forced vital capacity in 1 second; FVC, Forced vital capacity; TLC, Total lung capacity; RV, Residual volume; FRC,
Functional residual capacity; IC, Inspiratory capacity; DLCO, Diffusion lung capacity. Significantly different from Controls at P ≤ 0.05 (*) and P ≤ 0.01 (†).
Table 2 Summary of Cardiopulmonary Exercise Test
Endpoints in COPD and controls
COPD (n = 11) Controls (n = 11)
_VO2peak
L·min−1 1.10 ± 0.34 * 1.52 ± 0.41
mL·min−1·kg−1 16.1 ± 4.6 * 22.6 ± 7.0
_VO2peak pred;% 85 ± 29 106 ± 28
_VCO2peak; L⋅min‐1 1.08 ± 0.37 † 1.64 ± 0.50
_VE peak; L⋅min‐1 40.7 ± 9.5 * 62.5 ± 21.1
_VEpeak=MVV;% 84 ± 16 71 ± 19
Bf, breaths·min−1 31 ± 5 35 ± 8
SaO2,% 89.5 ± 4.3 † 94.5 ± 2.0
Heart rate
HR peak, beats·min
−1 121 ± 14 * 140 ± 20
HR age pred,% 81 ± 10 90 ± 13
O2 Pulse (mlbeat
−1) 9.1 ± 2.7 10.8 ± 2.0
Workrate
WR peak, Watts 57 ± 13 † 117 ± 34
WR pred,% 63 ± 21 † 103 ± 20
Borg dyspnea (0–10) 5.2 ± 1.1 5.8 ± 1.8
Borg leg Fatigue (0–10) 4.3 ± 1.2 5.6 ± 1.6
Abbreviations: _VO2peak, Peak volume of O2 consumed; _VO2peak, Peak volume of
CO2 produced; _VE peak, Peak expired ventilation rate; Bf peak, Peak breathing
frequency; SaO2, Arterial oxygen saturation; HR peak, Peak heart rate; O2 Pulse:
Oxygen pulse ( _VO2/HR); WR peak, Peak work rate. Significantly different from
controls at P ≤ 0.05 (*) and P ≤ 0.01 (†).
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to controls, suggesting a ventilatory limitation to exercise,
rather than any cardiovascular impairment (P > 0.05).Responses to exercise at a relative workload:
50% _VO2peak (EX1)
The target intensity for EX1 was set at 50% _VO2peak for
6 minutes (EX1). Accordingly, groups exercised at a
similar exercise intensity ( _VO2peak : 69% (COPD) versus
50% (controls); P > 0.05). Metabolic cost was not differ-
ent between groups in EX1 ( _VO2: 0.69 L⋅min
−1 (COPD)
versus 0.74 L⋅min−1 (controls); P > 0.05). Despite similar
workrates between groups (COPD: 15 W versus Controls:
23 W; P > 0.05), COPD patients exercised at a greater cap-
acity of their WRpeak (COPD: 25% versus Controls: 18%;
P ≤ 0.05). Patients and controls had similar PETCO2 and
PETO2 at rest, and in response to EX1 (P > 0.05).
The cerebro-and cardiovascular responses to EX1 are
summarized in Table 3. There were no differences be-
tween resting cerebro- or cardio-vascular variables be-
tween groups (P > 0.05). The two-factor analysis of
variance revealed that there was a significant main effect
of exercise in increasing VP , HR, and MBP (P ≤ 0.05).
CVC was not affected by exercise (P > 0.05). There was a
significant group x exercise interaction for MBP (mmHg)
(P ≤ 0.05), but not VP (cm·s−1) (P = 0.17). SaO2 decreased
with exercise, and this effect was the greatest in COPD
Table 3 Workrate, metabolic and respiratory parameters during rest and submaximal exercise
Exercise 1 (Relative Workload) Exercise 2 (Absolute Workload)
COPD (n=11) Control (n=11) COPD (n=9) Control (n=11)
BL1 EX1 BL1 EX1 BL2 EX2 BL2 EX2
Workrate, W - 15 ± 20 - 23 ± 19 - 30 - 30
WRmax,% - 25 ± 37 † - 18 ± 14 - 48 ± 7 † - 25 ± 11
Metabolic and Respiratory
_VE; L⋅min−1 8.9 ± 2.3 22.4 ± 7.1 7.3 ± 1.4 20.5 ± 5.1 11.8 ± 2.8* 27.9 ± 5.8 9.0 ± 1.4 21.0 ± 6.6
_VO2; L⋅min−1 0.28 ± 0.12 0.69 ± 0.28 0.27 ± 0.05 0.74 ± 0.17 0.27 ± 0.04 0.78 ± 0.22 0.28 ± 0.05 0.74 ± 0.19
_VO2peak;% 28 ± 10* 69 ± 31 19 ± 6 50 ± 11 25 ± 9 74 ± 30 20 ± 7 52 ± 20
_VCO2; L⋅min−1 0.23 ± 0.09 0.58 ± 0.24 0.22 ± 0.04 0.63 ± 0.17 0.26 ± 0.05 0.69 ± 0.18 0.25 ± 0.04 0.63 ± 0.17
PETCO2, mmHg 32.5 ± 3.2 34.9 ± 4.1 33.8 ± 2.1 36.0 ± 3.0 31.1 ± 3.3 34.4 ± 3.7 33.1 ± 1.9 35.4 ± 2.7
PETO2, mmHg 89.3 ± 5.0 87.6 ± 4.9 88.2 ± 4.8 86.3 ± 5.1 95.2 ± 5.2 89.4 ± 5.5 92.5 ± 5.2 88.0 ± 5.8
Abbreviations: WRmax, Work rate maximum; _VE, Minute ventilation; _VO2, Volume of oxygen uptake; _VCO2, Volume of carbon dioxide production; PETCO2, Pressure
of end-tidal CO2; PETO2, Pressure of end-tidal O2. *P ≤ 0.05 (different from controls at baseline). † P ≤ 0.05 (different between groups).
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(P ≤ 0.05).
In summary, exercise increased VP similarly in COPD
(42.8 to 50.2 cm·s−1) and controls (44.2 to 50.2 cm·s−1),
while working at a similar exercise intensity (P > 0.05), des-
pite COPD patients exhibiting a greater exercise-pressor
response and greater arterial oxygen desaturation.
Responses to exercise at absolute workload:
30 watts (EX2)
Physiological description of the exercise protocol is sum-
marized in Table 4. All subjects cycled at a workrate of
30 W for 6 minutes (EX2). By design, there was no dif-
ference between _VO2 between groups ( _VO2: 0.78 L⋅min
−1
(COPD) versus 0.74 L⋅min−1 (controls); P > 0.05). There
was a trend for COPD patients to be exercising at a greaterTable 4 Cerebro- and cardio-vascular responses to submaxim
Exercise 1
COPD Control
BL1 EX1 BL1 EX1
Cerebrovascular
VP; cm⋅s−1 42.8 ± 10.4 52.4 ± 10.3 44.2 ± 13.6 50.2 ± 13.
% 25 ± 22 15 ± 13
CVC, cm·s−1·mmHg−1 0.46 ± 0.11 0.47 ± 0.09 0.49 ± 0.15 0.50 ± 0.1
% 5 ± 15 3 ± 8
Cardiovascular
HR, bpm 67 ± 7 93 ± 11 66 ± 8 90 ± 14
MBP, mmHg 94.5 ± 8.7 113.7 ± 18.1 92.0 ± 13.2 101.8 ± 12
% 20 ± 13 11 ± 8
SaO2,% 94 ± 2 91 ± 4 95 ± 1 94 ± 2
Abbreviations: VP; Peak cerebral blood flow velocity; CVC, cerebrovascular conducta
Arterial oxygen saturation; * P ≤ 0.05 (main effect of exercise); # P ≤ 0.05 (main effectrelative exercise intensity than controls ( _VO2peak : 74%
(COPD) versus 52% (controls); P = 0.08). Despite the same
workrate between groups, COPD patients exercised at a
greater capacity of their WRpeak (COPD: 48% versus Con-
trols: 25%; P ≤ 0.01). Patients and controls had similar
PETCO2 and PETO2 at rest, and in response to EX2.
The cerebro-and cardiovascular responses to EX2
are summarized in Table 3, and individual stage means
are presented in Figure 1. There were no differences
between resting cerebro- or cardio-vascular variables
between groups (P > 0.05). The two-factor analysis of
variance revealed that there was a significant main ef-
fect of exercise in increasing VP , HR, and MBP, and
decreasing SaO2 (P ≤ 0.05). There was a significant group
by exercise interaction for VP (cm·s−1) (P ≤ 0.05). Exer-
cise significantly decreased SaO2 overall (P < 0.01), butal exercise in COPD and controls
Exercise 2
COPD Control
P BL2 EX2 BL2 EX2 P
3 * 40.2 ± 12.1 51.1 ± 11.5 43.8 ± 12.5 48.7 ± 11.9 * †
* 31 ± 26 13 ± 10 * # †
5 0.45 ± 0.13 0.46 ± 0.90 0.47 ± 0.14 0.49 ± 0.15
9 ± 27 4 ± 8
* 69 ± 8 101 ± 10 71 ± 12 92 ± 15 * †
.7 * † 95.4 ± 9.6 112.9 ± 27.0 94.5 ± 15.2 103.7 ± 24.2 *
* 18 ± 22 9 ± 10 *
* # † 95 ± 1 91 ± 4 96 ± 1 95 ± 1 * # †
nce (CVC = VP/MBP); MBP, Mean arterial blood pressure; HR, Heart rate; SaO2,
of grouping); † P ≤ 0.05 (exercise x grouping interaction).
Figure 1 Continuous representation of the physiological responses to two, 6-minute exercise periods in women with moderate COPD
(thick line) and healthy age-matched controls (thin line). Exercise 1 (EX1; 50% _VO2peak) and Exercise 2 (EX2; 30 Watts) were separated by
6-minutes of resting recovery. a) Peak cerebral blood flow velocity in the middle cerebral artery (VP); b) mean arterial blood pressure (MBP); c)
arterial oxygen saturation (SaO2); d) heart rate (HR); e) volume of oxygen consumption ( _VO2); and f) volume of carbon dioxide production ( _VCO2).
Data represent 15-second averages. Cycling exercise periods are shaded.
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turated at a greater rate than controls as exhibited
statistically by a grouping by exercise interaction effect
(P <0.01).
In summary, exercise increased VP to a greater extent
in COPD patients (40.2 to 51.1 cm·s−1) compared to
controls (43.8 to 48.7 cm·s−1), while working at 30 Watts
(and an equivalent _VO2 ). At this workload, however,
there was a trend for COPD patients to be working at a
higher percentage of maximum capacity than the control
subjects. Blood pressure increased with exercise, but
changes were similar between groups.
Relationships between fitness, disease severity, and
cerebrovascular measurements during exercise
At rest, there was no relationship between fitness status,
disease severity, SaO2, PETCO2, and blood pressure oncerebrovascular measures. In both groups, and in both
exercise conditions, participants with lower baseline VP
were more likely to have low exercise VP, and vice versa
(EX1: R2 = 0.75, P < 0.01; EX2: R2 = 0.78, P <0.01). Fur-
thermore, individuals with lower baseline VP were more
likely to have a greater absolute increase in exercise VP
(EX1: R2 = 0.18, P ≤ 0.05; EX2: R2 = 0.29, P < 0.01). Per-
cent change in MBP was positively associated with
change in VP (EX1: R2 = 0.36, P < 0.01; EX2: R2 = 0.22,
P ≤ 0.05). There was no relationship between cerebrovas-
cular variables and SaO2 during exercise. In EX2, the
change in PETCO2 with exercise was positively related
to the changes in VP and CVC ( VP: R2 = 0.37, P < 0.01;
CVC: R2 = 0.40, respectively, P < 0.01). There was no sig-
nificant correlations between _VO2peak and VP , MBP,
or CVC (P > 0.05) in either EX1 or EX2 (all subjects
combined).
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Our main findings are that 1) when patients with mild
to moderate COPD exercise at the same intensity to
healthy controls, the CBF response is similar; and 2) when
comparing CBF at a matched O2 demand (i.e., 30 Watts),
CBF is elevated in this cohort of COPD patients. From
these results, it is apparent that COPD does not have a
detrimental effect on cerebral blood flow during moderate
intensity exercise. The mechanisms underlying the in-
creased CBF in COPD at higher workloads needs to be in-
vestigated further.
Cerebral blood flow velocity has consistently been
shown to increase in healthy individuals during mild to
moderate exercise intensity [16,21-23], and seems to
be intensity dependent [24]. Although mechanisms are
not fully elucidated [25], important regulators of the
exercise-induced CBF response include: cortical activa-
tion [26], arterial blood pressure [27], cardiac output
[21], and blood gases (particularly PaCO2) [28]. Compara-
tive studies are particularly lacking in the area of ageing
and disease. Consequential alterations of CBF are appar-
ent with age, however, physical fitness has been shown
to offset these changes [1,15]. Aerobic capacity appears
to be an important determinant in cerebrovascular health
with ageing, as it has been shown to be positively corre-
lated with cerebrovascular CO2 reactivity [29], and better
cognitive outcomes [15]. Current opinion suggests that
COPD represents a case of advanced ageing [30], which
may make these patients particularly susceptible to alter-
ations in cerebrovascular responses.
We reasoned that the known vascular consequences
associated with COPD, including endothelial dysfunction
[31], and increased arterial stiffness [32] would play a
detrimental role in the CBF response to exercise. A re-
cent study suggests that physical fitness (i.e., 6MWD)
has a favorable effect on endothelial function in COPD
patients [33]. We have furthermore shown that women
with moderate COPD exhibit a nearly two-fold reduc-
tion in the expected CBF response to CO2 [7]. It is likely
that during a more modest cerebrovascular challenge
(e.g., submaximal exercise versus hypercapnia), the cere-
brovascular response remains intact, despite underlying
vascular pathologies that may exist.
We found patients to have decreases in SaO2 during
exercise in response to maximal and submaximal exer-
cise. As hypoxia is known to stimulate blood flow, it is
interesting that we did not find a relationship between
individuals with lower SaO2 during exercise and in-
creased CBF. However, it is possible that increased CBF,
as seen in COPD during more intense exercise (e.g., EX2),
could be partially driven by decreased SaO2, in a regulatory
effort to increase cerebral oxygen delivery.
Results from a study investigating cerebral hemo-
dynamics in severe COPD during exhaustive exercisesuggest increased frontal cortex O2 delivery at the end of
exhaustive normoxic exercise, in conjunction with in-
creased CBF, despite exercise induced hypoxemia [11].
These results would suggest a regulatory difference, as it
has alternatively been shown in healthy hypoxemic in-
dividuals that CBF is decreased (from rest) during ex-
haustive exercise [34]. The differences between these
studies was explained by the lack of hyperventilation
in COPD which maintained (and even increased) PaCO2 ,
causing a vasodilatory response. However, caution is war-
ranted as this study does not allow for an accurate com-
parison with an age-matched control group. The “normal”
hyperventilation-induced hypocapnia evident during high-
intensity exercise as been shown to be blunted in healthy
older individuals, which in turn leads to maintenance of
PaCO2, and CBF [35]. In patients with terminal lung dis-
ease, Jensen et al. [12] has shown continuous increases in
CBF, with a slight reduction in cerebral oxygenation at
end-exercise in room air, without changes in PaCO2. It is
therefore likely, that the CBF response in COPD depends
on several aspects, such as disease severity, blood gases, ex-
ercise intensity, and physical fitness. We are hesitant to
draw conclusions based on PaCO2, as this variable was not
measured in our study. However, COPD patients continue
to increase _VE in EX2, which would not support the
hypoventilation/increased PaCO2 theory.
Cardio-pulmonary interactions during exercise in COPD
have the potential to have an adverse influence on CBF.
Increased expiratory loading and dynamic hyperinflation
(DH) during exercise may impair venous return, and con-
sequently lead to a reduction in right heart preload, and
ultimately stroke volume. O2 pulse is commonly used
as a surrogate measure of stroke volume (and cardiac
efficiency). Studies have shown DH to be negatively corre-
lated with O2 Pulse during incremental exercise in COPD
[36,37]. Furthermore, resting hyperinflation (IC/TLC) was
associated with a reduction of O2 pulse at peak exercise.
We did not find a difference in O2 pulse at peak exercise
between COPD patients and controls (Table 2), and take
this to indicate that cardiac function was not impaired in
our patients. Despite COPD patients in this study having
significantly lower IC/TLC ratio at rest (37% versus 49%),
this level of hyperinflation is noticeably less when com-
pared to results of the aforementioned studies which re-
ported DH during exercise. Furthermore, the role of DH
in mild-moderate COPD remains to be clearly defined.
Lastly, although cardiac output remains an important de-
terminant in cerebrovascular regulation, reductions in car-
diac output (by lower body negative pressure) reduce CBF,
but seem to be less important during exercise compared
to the resting state, which has been explained as a
counter-regulatory activation of the sympathetic nervous
system [38]. Overall, we speculate, that DH is not a major
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population. As this remains beyond the scope of this
study, it should be considered in future studies.
One strength of our study is that it includes data com-
paring the physiological response during both as exercise
challenge that is a fixed percentage of each person’s
maximal workload, and an absolute workload - which
represents a value that may be a more realistic occur-
rence in activities of daily living. Although we found that
patients with mild and moderate COPD have a normal
CBF response at 50% _VO2peak , it is important to high-
light that this workload is equivalent to ~2.9 METS,
which would equate to light housework such as self care,
washing dishes, and walking to a parking lot [39]. When
physical demands are slightly increased to 30 Watts
(~3.2 METS), these COPD patients further increase CBF.
The importance of absolute requirements are highlighted
by Paterson et al. [40] who report that a relative _VO2
of ~15 mL O2·kg
−1·min−1 is required for independent liv-
ing in the aging population. During moderate activities
(e.g., vigorous cleaning, sweeping, etc.), COPD patients
would be exposed to increased aerobic demand, which
may have cerebrovascular implications, including a re-
duced cerebrovascular reserve capacity compared to
healthy controls. This remains highly speculative, and the
implications of this are unclear at this time. Although we
do not have measures of habitual activity, we have previ-
ously shown a significant, positive agreement between
self-reported physical and _VO2max in healthy, older
women [41]. In this same study, fitness was correlated
with better vascular outcomes during exercise [15]. We
therefore suspect that individuals in the present study
who have a higher _VO2max are also more physically ac-
tive, although this needs to be confirmed in future re-
search. Conversely, it is possible that frequent increases
in CBF may pose a vascular benefit to COPD patients,
whereby increases in CBF result in shear stress on the
vascular endothelium, thus providing beneficial adapta-
tions through the up-regulation of nitric oxide synthase
[42]. In contrast, modest activities increase CBF in COPD
and may limit the supply of blood flow available for add-
itional challenges, such as cognitive tasks.
Our selection of mild – moderate COPD patients in-
cludes 9 of 11 patients with GOLD II, moderate COPD.
Of these 11 patients, 2 could not complete a 6-minute
workload of 30 Watts. We believe that more severe pa-
tients would have further difficulty completing 2×6-min
bouts of cycling exercise. Further, our selected cohort of
COPD patients represents the patients that are most
likely either still physically active, or still have the poten-
tial to become more active, and we would therefore gain
the greatest insight into studying this population. Women
in particular have lower _VO2max , smaller lung volumes,and exhibit greater dyspnea at a similar _VO2 compared to
men [43]. Finally, a homogeneous sample of women re-
duces additional heterogeneity between subjects, and is
particularly important in this smaller sample size.
Limitations
Transcranial Doppler ultrasound is a commonly used,
non-invasive tool to measure the velocity of blood in the
MCA. The MCA provides ~ 80% of the blood flow to
the brain, and perfuses the frontal and temporal lobe, in-
cluding the motor-sensory cortex, which is activated
during exercise. This technique offers several advantages
over other methodologies because of its non-invasive
properties, and high temporal resolution [44,45]. One
drawback of using this method, however, is the assump-
tion that the MCA diameter remains constant, allowing
us to infer that velocity represents flow. The regulation
of CBF is thought to occur in the small arterioles, such
that the large basal cerebral arteries maintain a constant
diameter thus, providing an accurate representation of
CBF [16,45].
We firstly chose to compare the steady-state CBF re-
sponse at a relative exercise intensity. Secondarily, we
studied the physiological response between COPD and
controls at an absolute workload. We acknowledge that
at an absolute workload participants are working at a
different relative exercise capacity, which introduces
confounding variables. It is therefore difficult to inter-
pret the specific mechanisms involved in the observed
differences in CBF during this stage. However, we be-
lieve this exercise workload to be of significant import-
ance and these findings notable.
Lastly, a limitation of our study was the absence of
arterial blood gases as part of our methodology. We
therefore are precluded from making a conclusion re-
garding the influence of PaCO2 on the regulation of CBF
during exercise in COPD.
Conclusion
Cerebral blood flow responsiveness appears to be normal
in patients with mild to moderate COPD compared to
healthy controls when exercising at a moderate intensity
(50% _VO2max ), but not when exercising at a slightly
greater, matched workload (i.e., 30 Watts). It is likely
that decreased physical fitness contribute to this. These
results have implications for normal activities of daily
living such as household activities in which COPD pa-
tients would likely experience greater increases in CBF,
thereby decreasing the cerebral vascular reserve.
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